Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lentigo Maligna Treated With Microscopically Controlled Surgery: A 194-Patient Retrospective Study.

Gloria Baeza-Hernández1,2,3, Ruggero Moro1,4, Celia Requena1

  • 1Dermatology Department, Instituto Valenciano de Oncología, Valencia, Spain.

International Journal of Dermatology
|May 15, 2026
PubMed
Summary

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Association Between pTERT Promoter Mutation Subtypes and Survival Outcomes in BRAF-Mutant Metastatic Melanoma Treated With BRAF/MEK Inhibitors: An Exploratory Study.

International journal of dermatology·2026
Same author

Superficial (Cutaneous) Tumors Exhibiting Morphological and Phenotypic Differentiation Toward Smooth Muscle and Pericytic Lineages.

International journal of surgical pathology·2026
Same author

Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB-IIC melanoma.

Melanoma research·2026
Same author

Is Neoadjuvancy with Imatinib Useful Before Mohs Surgery in Locally Advanced Dermatofibrosarcoma Protuberans? Experience of a Dermato-Oncology Referral Center.

International journal of molecular sciences·2026
Same author

Improving Risk Stratification for SLNB in Elderly Patients With Melanoma: The SENTINOLD Nomogram.

International journal of dermatology·2026
Same author

International Dermoscopy Society consensus recommendations for the management of lentigo maligna.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
This summary is machine-generated.

Paraffin-embedded microscopically controlled surgery (MCS) offers excellent margin control for lentigo maligna (LM) and lentigo maligna melanoma (LMM). This technique demonstrates a low local recurrence rate, supporting its clinical value in treating these skin conditions.

Area of Science:

  • Dermatology and Surgical Oncology
  • Cutaneous Oncology
  • Surgical Pathology

Background:

  • Further research is needed to establish the clinical significance of paraffin-embedded microscopically controlled surgery (MCS) for lentigo maligna (LM) and lentigo maligna melanoma (LMM).
  • Accurate margin assessment is crucial for effective treatment and minimizing recurrence of these melanocytic neoplasms.

Purpose of the Study:

  • To evaluate the efficacy of paraffin-embedded MCS in achieving negative margins and its association with local recurrence rates in patients with LM and LMM.
  • To assess the clinical value of staged excision using paraffin-embedded MCS for LM and LMM.

Main Methods:

  • Retrospective observational study of histologically confirmed LM and LMM cases treated exclusively with paraffin-embedded MCS (staged excision).
Keywords:
Mohs surgerydermatologylentigo malignalentigo maligna melanomaskin neoplasmsslow Mohs

Related Experiment Videos

  • Inclusion criteria required definitive treatment and a minimum follow-up of 6 months for recurrence-free cases.
  • Data collected included patient demographics, tumor characteristics, surgical margins, and local recurrence (LR) rates.
  • Main Results:

    • 194 patients were included, with a median age of 72.5 years; most were primary tumors (82%) located on the face.
    • All patients achieved negative margins with paraffin-embedded MCS.
    • A low local recurrence (LR) rate of 3.6% (7/194) was observed over a median follow-up of 34 months, with a trend towards higher LR in LMM (7.5%) versus LM (2.1%).

    Conclusions:

    • Paraffin-embedded MCS provides reliable margin control for LM and LMM.
    • The technique is associated with a low local recurrence rate, indicating its clinical value in managing these conditions.
    • Staged excision using paraffin-embedded MCS is an effective treatment modality for lentigo maligna and lentigo maligna melanoma.